{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T08:39:29Z","timestamp":1789720769759,"version":"4.0.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000150","name":"Canadian Breast Cancer Research Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001513","name":"Breast Cancer Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001513","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.isci.2020.101229","type":"journal-article","created":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T02:12:15Z","timestamp":1591063935000},"page":"101229","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Integrating Systems Biology and an Ex\u00a0Vivo Human Tumor Model Elucidates PD-1 Blockade Response Dynamics"],"prefix":"10.1016","volume":"23","author":[{"given":"Munisha","family":"Smalley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Przedborski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saravanan","family":"Thiyagarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moriah","family":"Pellowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilesh","family":"Brijwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debika","family":"Datta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misti","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basavaraja U.","family":"Shanthappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidushi","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kodaganur S.","family":"Gopinath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.C.","family":"Doval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.S.","family":"Sabitha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaspar","family":"Taroncher-Oldenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biswanath","family":"Majumder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradip","family":"Majumder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Kohandel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Goldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2020.101229_bib1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4049\/jimmunol.172.1.61","article-title":"Sustained IL-12 signaling is required for Th1 development","volume":"172","author":"Athie-Morales","year":"2004","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.isci.2020.101229_bib2","first-page":"1325","article-title":"Detection of human papilloma virus and risk factors among patients with head and neck squamous cell carcinoma attending a Tertiary Referral Centre in South India","volume":"19","author":"Bandhary","year":"2018","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.isci.2020.101229_bib3","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.oraloncology.2013.09.008","article-title":"The clinical impact of HPV tumor status upon head and neck squamous cell carcinomas","volume":"50","author":"Benson","year":"2014","journal-title":"Oral Oncol."},{"key":"10.1016\/j.isci.2020.101229_bib4","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1093\/jnci\/djt253","article-title":"From bench to bedside: does preclinical practice in translational oncology need some rebuilding?","volume":"105","author":"Bertotti","year":"2013","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.isci.2020.101229_bib8","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1158\/2159-8290.CD-15-1545","article-title":"Analysis of immune signatures in longitudinal tumor samples yields insight into biomarkers of response and mechanisms of resistance to immune checkpoint blockade","volume":"6","author":"Chen","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.isci.2020.101229_bib9","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1177\/0037549703040943","article-title":"Experimental design in systems biology based on parameter sensitivity analysis using a Monte Carlo method: a case study for the TNF alpha-mediated NF-kappaB signal transduction pathway","volume":"79","author":"Cho","year":"2003","journal-title":"Simulation"},{"key":"10.1016\/j.isci.2020.101229_bib10","doi-asserted-by":"crossref","first-page":"eaar3593","DOI":"10.1126\/science.aar3593","article-title":"Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy","volume":"362","author":"Cristescu","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.isci.2020.101229_bib11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2015.08.068","article-title":"Preclinical mouse cancer models: a maze of opportunities and challenges","volume":"163","author":"Day","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.isci.2020.101229_bib12","first-page":"356","article-title":"Preclinical cancer models and biomarkers for drug development: new technologies and emerging tools","volume":"8","author":"Dhandapani","year":"2017","journal-title":"J.\u00a0Mol. Biomark. Diagn."},{"key":"10.1016\/j.isci.2020.101229_bib13","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1128\/IAI.01328-06","article-title":"Th1 and Th2 cells help CD8 T-cell responses","volume":"75","author":"Ekkens","year":"2007","journal-title":"Infect. Immun."},{"key":"10.1016\/j.isci.2020.101229_bib14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.oraloncology.2018.04.008","article-title":"Nivolumab vs investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression","volume":"81","author":"Ferris","year":"2018","journal-title":"Oral Oncol."},{"key":"10.1016\/j.isci.2020.101229_bib15","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/nature11005","article-title":"Systematic identification of genomic markers of drug sensitivity in cancer cells","volume":"483","author":"Garnett","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.isci.2020.101229_bib16","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1056\/NEJMe1705692","article-title":"Cancer immunotherapy trials not immune from imprecise selection of patients","volume":"376","author":"Garon","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.isci.2020.101229_bib17","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1158\/1535-7163.MCT-17-0386","article-title":"Tumor mutational burden as an independent predictor of response to immunotherapy in diverse cancers","volume":"16","author":"Goodman","year":"2017","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.isci.2020.101229_bib18","first-page":"7","article-title":"An approach to the preliminary-analysis of environmental systems","volume":"12","author":"Hornberger","year":"1981","journal-title":"Environ. Manage."},{"key":"10.1016\/j.isci.2020.101229_bib19","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1242\/dmm.031260","article-title":"Human tissue models in cancer research: looking beyond the mouse","volume":"10","author":"Jackson","year":"2017","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.isci.2020.101229_bib20","doi-asserted-by":"crossref","first-page":"6408","DOI":"10.1158\/0008-5472.CAN-14-0813","article-title":"Direct chemosensitivity monitoring ex\u00a0vivo on undissociated melanoma tumor tissue by impedance spectroscopy","volume":"74","author":"Jahnke","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2020.101229_bib21","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1158\/2159-8290.CD-17-0833","article-title":"Ex\u00a0vivo profiling of PD-1 blockade using organotypic tumor spheroids","volume":"8","author":"Jenkins","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.isci.2020.101229_bib22","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s12282-016-0688-1","article-title":"Advances in personalized cancer immunotherapy","volume":"24","author":"Kakimi","year":"2017","journal-title":"Breast Cancer"},{"key":"10.1016\/j.isci.2020.101229_bib23","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1158\/0008-5472.CAN-16-1121","article-title":"Ex\u00a0vivo explant cultures of non-small cell lung carcinoma enable evaluation of primary tumor responses to anticancer therapy","volume":"77","author":"Karekla","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2020.101229_bib24","doi-asserted-by":"crossref","first-page":"5515","DOI":"10.4049\/jimmunol.166.9.5515","article-title":"Il-12 enhances CD8 T\u00a0cell homeostatic expansion","volume":"166","author":"Kieper","year":"2001","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.isci.2020.101229_bib26","first-page":"350","article-title":"Cancer immunotherapy and personalized medicine: emerging technologies and biomarker-based approaches","volume":"8","author":"Maciejko","year":"2017","journal-title":"J.\u00a0Mol. Biomark. Diagn."},{"key":"10.1016\/j.isci.2020.101229_bib27","doi-asserted-by":"crossref","first-page":"6169","DOI":"10.1038\/ncomms7169","article-title":"Predicting clinical response to anticancer drugs using an ex\u00a0vivo platform that captures tumour heterogeneity","volume":"6","author":"Majumder","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2020.101229_bib28","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13058-016-0737-x","article-title":"Quantitative assessment of the spatial heterogeneity of tumor-infiltrating lymphocytes in breast cancer","volume":"18","author":"Mani","year":"2016","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.isci.2020.101229_bib29","doi-asserted-by":"crossref","first-page":"FSO190","DOI":"10.4155\/fsoa-2017-0003","article-title":"Ex\u00a0vivo tumor culture systems for functional drug testing and therapy response prediction","volume":"3","author":"Meijer","year":"2017","journal-title":"Future Sci. OA"},{"key":"10.1016\/j.isci.2020.101229_bib30","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.cell.2017.09.028","article-title":"Tumor and microenvironment evolution during immunotherapy with nivolumab","volume":"171","author":"Riaz","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.isci.2020.101229_bib31","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.bcp.2013.06.020","article-title":"Animal models of disease: pre-clinical animal models of cancer and their applications and utility in drug discovery","volume":"87","author":"Ruggeri","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.isci.2020.101229_bib32","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1200\/JCO.2004.04.077","article-title":"Chemotherapy sensitivity and resistance assays: a systematic review","volume":"22","author":"Samson","year":"2004","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.isci.2020.101229_bib33","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nri2711","article-title":"The regulation of IL-10 production by immune cells","volume":"10","author":"Saraiva","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.isci.2020.101229_bib34","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/nrc2820","article-title":"Cell line-based platforms to evaluate the therapeutic efficacy of candidate anticancer agents","volume":"10","author":"Sharma","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.isci.2020.101229_bib35","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1158\/0008-5472.CAN-17-0502","article-title":"An ex\u00a0vivo platform for the prediction of clinical response in multiple myeloma","volume":"77","author":"Silva","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2020.101229_bib36","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.cell.2016.12.022","article-title":"Systemic immunity is required for effective cancer immunotherapy","volume":"168","author":"Spitzer","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.isci.2020.101229_bib37","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1056\/NEJMsb1607705","article-title":"Limits to personalized cancer medicine","volume":"375","author":"Tannock","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.isci.2020.101229_bib39","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.canlet.2013.09.016","article-title":"A personalized view on cancer immunotherapy","volume":"352","author":"Wayteck","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.isci.2020.101229_bib40","doi-asserted-by":"crossref","first-page":"a026583","DOI":"10.1101\/cshperspect.a026583","article-title":"Spatial heterogeneity in the tumor microenvironment","volume":"6","author":"Yuan","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.isci.2020.101229_bib41","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.7150\/jca.24577","article-title":"Current status and future directions of cancer immunotherapy","volume":"9","author":"Zhang","year":"2018","journal-title":"J.\u00a0Cancer"},{"key":"10.1016\/j.isci.2020.101229_bib42","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1049\/iet-syb.2011.0015","article-title":"Sensitivity analysis approaches applied to systems biology models","volume":"5","author":"Zi","year":"2011","journal-title":"IET Syst. Biol."},{"key":"10.1016\/j.isci.2020.101229_bib43","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.febslet.2005.01.009","article-title":"In silico identification of the key components and steps in IFN-gamma induced JAK-STAT signaling pathway","volume":"579","author":"Zi","year":"2005","journal-title":"FEBS Lett."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004220304144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004220304144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T20:04:24Z","timestamp":1766174664000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004220304144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S2589004220304144"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2020.101229","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrating Systems Biology and an Ex\u00a0Vivo Human Tumor Model Elucidates PD-1 Blockade Response Dynamics","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2020.101229","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors.","name":"copyright","label":"Copyright"}],"article-number":"101229"}}